{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:32:37Z","timestamp":1790685157799,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","award":["STRF-7740-2016"],"award-info":[{"award-number":["STRF-7740-2016"]}],"id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G10000758"],"award-info":[{"award-number":["G10000758"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_15028"],"award-info":[{"award-number":["MC_PC_15028"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M004821\/1"],"award-info":[{"award-number":["MR\/M004821\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000362","name":"Asthma UK","doi-asserted-by":"publisher","award":["CH11SJ"],"award-info":[{"award-number":["CH11SJ"]}],"id":[{"id":"10.13039\/501100000362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["788575"],"award-info":[{"award-number":["788575"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejphar.2020.173839","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T18:04:00Z","timestamp":1608833040000},"page":"173839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication"],"prefix":"10.1016","volume":"893","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-7286","authenticated-orcid":false,"given":"Andrea","family":"Marcellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawid","family":"Swieboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"Gued\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart N.","family":"Farrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7848-1217","authenticated-orcid":false,"given":"Paolo","family":"Casolari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2731-5809","authenticated-orcid":false,"given":"Marco","family":"Contoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian L.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Solari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173839_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/164_2016_62","article-title":"Glucocorticosteroids","volume":"237","author":"Barnes","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173839_bib2","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.1073\/pnas.1017296108","article-title":"Glucocorticoids target suppressor of cytokine signalling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation","volume":"108","author":"Bhattacharyya","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173839_bib3","doi-asserted-by":"crossref","first-page":"18114","DOI":"10.1073\/pnas.0909125106","article-title":"Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor","volume":"106","author":"Biggadike","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173839_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-lambda production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2020.173839_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00451-2017","article-title":"Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD","volume":"50","author":"Contoli","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2020.173839_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027898","article-title":"Budesonide and formoterol reduce early innate anti-viral immune responses in vitro","volume":"6","author":"Davies","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173839_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1165\/rcmb.2005-0385OC","article-title":"Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells","volume":"34","author":"Edwards","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2020.173839_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/jir.2010.0127","article-title":"The interferon inducible gene: Viperin","volume":"31","author":"Fitzgerald","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.ejphar.2020.173839_bib9","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1128\/MCB.00146-10","article-title":"The type I interferon signalling pathway is a target for glucocorticoid inhibition","volume":"30","author":"Flammer","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2020.173839_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1183\/09031936.00223113","article-title":"Human rhinovirus infection during naturally occurring COPD exacerbations","volume":"44","author":"George","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2020.173839_bib11","author":"Global Initiative for Asthma"},{"key":"10.1016\/j.ejphar.2020.173839_bib12","author":"Global Initiative for Chronic Obstructive Lung Disease"},{"key":"10.1016\/j.ejphar.2020.173839_bib13","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaip.2018.01.025","article-title":"Inhaled corticosteroids safety and adverse effects in patients with asthma","volume":"6","author":"Heffler","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ejphar.2020.173839_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1753465815618113","article-title":"The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma","volume":"10","author":"Hewitt","year":"2016","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.ejphar.2020.173839_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2020.173839_bib16","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jaci.2011.10.024","article-title":"Asthma exacerbations: origin, effect, and prevention","volume":"128","author":"Jackson","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2020.173839_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/CMR.00077-12","article-title":"Human rhinoviruses","volume":"26","author":"Jacobs","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejphar.2020.173839_bib18","article-title":"Lower airway virology in health and disease-from invaders to symbionts","volume":"54","author":"Jankauskait\u0117","year":"2018","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ejphar.2020.173839_bib19","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bmj.310.6989.1225","article-title":"Community study of role of viral infections in exacerbations of asthma in 9-11 year old children","volume":"310","author":"Johnston","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2020.173839_bib20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","article-title":"Glucocorticoid receptor signalling in health and disease","volume":"34","author":"Kadmiel","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2020.173839_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mce.2007.07.003","article-title":"Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects","volume":"275","author":"Kassel","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2020.173839_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4168\/aair.2012.4.3.116","article-title":"Updates in the relationship between human rhinovirus and asthma","volume":"4","author":"Kim","year":"2012","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.ejphar.2020.173839_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pupt.2017.10.004","article-title":"Long-acting \u03b22-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation","volume":"48","author":"Kuo","year":"2018","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173839_bib24","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jaci.2009.03.010","article-title":"In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects","volume":"123","author":"Lopez-Souza","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2020.173839_bib25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1164\/rccm.201006-0833OC","article-title":"Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation","volume":"183","author":"Mallia","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2020.173839_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/jir.2008.0050","article-title":"Differential regulation of the OASL and OAS1 genes in response to viral infections","volume":"29","author":"Melchjorsen","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.ejphar.2020.173839_bib27","doi-asserted-by":"crossref","first-page":"16598","DOI":"10.1073\/pnas.0909192106","article-title":"Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression","volume":"106","author":"Muzikar","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173839_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1124\/mol.107.038794","article-title":"Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?","volume":"72","author":"Newton","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173839_bib29","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/bmj.307.6910.982","article-title":"Respiratory viruses and exacerbations of asthma in adults","volume":"307","author":"Nicholson","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2020.173839_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.steroids.2009.09.002","article-title":"The human glucocorticoid receptor: molecular basis of biologic function","volume":"75","author":"Nicolaides","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.ejphar.2020.173839_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","article-title":"Asthma","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173839_bib32","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.05.028","article-title":"Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kB and c-Jun N-terminal kinase activation","volume":"132","author":"Papi","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2020.173839_bib33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1164\/rccm.200805-670OC","article-title":"Gene expression profiles during in vivo human rhinovirus infection: insights into the host response","volume":"178","author":"Proud","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2020.173839_bib34","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0140-6736(17)31222-9","article-title":"Chronic obstructive pulmonary disease","volume":"389","author":"Rabe","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173839_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.0300372101","article-title":"Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects","volume":"101","author":"Sch\u00e4cke","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173839_bib36","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41467-018-04574-1","article-title":"Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations","volume":"9","author":"Singanayagam","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2020.173839_bib37","doi-asserted-by":"crossref","first-page":"L893","DOI":"10.1152\/ajplung.00253.2019","article-title":"Antiviral immunity is impaired in COPD patients with frequent exacerbations","volume":"317","author":"Singanayagam","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2020.173839_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001178","article-title":"Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium","volume":"6","author":"Slater","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2020.173839_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pharmthera.2015.05.001","article-title":"Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds","volume":"152","author":"Sundahl","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2020.173839_bib40","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jaci.2012.03.044","article-title":"Rhinovirus 16-induced IFN-\u03b1 and IFN-\u03b2 are deficient in bronchoalveolar lavage cells in asthmatic patients","volume":"129","author":"Sykes","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2020.173839_bib41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/infdis\/jix640","article-title":"In vitro model of fully differentiated human nasal epithelial cells infected with rhinovirus reveals epithelium-initiated immune responses","volume":"217","author":"Tan","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2020.173839_bib42","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1038\/srep07176","article-title":"Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon","volume":"4","author":"Thomas","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173839_bib43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.10.013","article-title":"Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes","volume":"49","author":"Uhlenhaut","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2020.173839_bib44","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/bph.12232","article-title":"Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profile","volume":"169","author":"Uings","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173839_bib45","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/cdd.2015.1","article-title":"The transrepression arm of glucocorticoid receptor signalling is protective in mutant huntingtin-mediated neurodegeneration","volume":"22","author":"Varadarajan","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2020.173839_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002070","article-title":"MDA5 and TLR3 initiate pro-inflammatory signalling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness","volume":"7","author":"Wang","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2020.173839_bib47","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.20041901","article-title":"Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus","volume":"201","author":"Wark","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2020.173839_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrm.2016.152","article-title":"Glucocorticoid receptor control of transcription: precision and plasticity via allostery","volume":"18","author":"Weikum","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2020.173839_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.resinv.2019.12.005","article-title":"Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells","volume":"58","author":"Yamaya","year":"2020","journal-title":"Respiratory Invest."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920309444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920309444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:12:20Z","timestamp":1762143140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920309444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":49,"alternative-id":["S0014299920309444"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173839","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173839"}}